Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (9 ops.)
Latest filing published 01 Oct 2026 for KESTRA MEDICAL TECHNOLOGIES, LTD., €86k. Read the official filing
Filing timeline
BuySaleRaymond W. Cohen
Insider track record
Disclosed buys
2
Disclosed sells
9
Signal history
Closed purchases
Market purchases
2
Positive at T+90
100%
Median T+90
+32.2%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +27.2%Entry US$19.93 · Close at T+90 US$25.35
- +37.3%Entry US$17.87 · Close at T+90 US$24.53
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Raymond W. Cohen: trading record in brief
This profile gathers the share dealings of Raymond W. Cohen across 5 companies, led by Axonics, Inc., Kestra Medical Technologies, Ltd. and RxSight, Inc. The record holds 22 filings, for trades running from 10 May 2021 to 30 September 2026.
The open-market side counts 2 purchases for €441k alongside 9 sales for €12.9M. The net balance comes to €12.5M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 8 share grants and 2 option exercises. In 2026 alone, the filings show 1 purchase and 1 sale.
The latest filing, published on 1 October 2026, reports an open-market sale of €86k in Kestra Medical Technologies, Ltd. The last purchase on record was published on 30 March 2026, which is 202 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Raymond W. Cohen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
3,330 shares@ US$29.2805Common SharesSEC:0001193125-26-410928:0
7,217 sharesCommon SharesSEC:0001193125-26-388306:0
30,864 sharesCommon StockSEC:0001193125-26-275834:0
10,000 shares@ US$19.9839.2% of flowCommon SharesSEC:0001193125-26-132324:0
Canonical exit: 24 Jun 2026 (T+90)
44,030 shares0Common StockSEC:0001493152-26-002663:0
17,000 shares@ US$17.0060.8% of flowCommon SharesSEC:0000950170-25-113631:0
Canonical exit: 5 Jun 2025 (T+90)
35,668 shares0Common StockSEC:0000950170-25-102098:0
12,994 sharesCommon SharesSEC:0000950170-25-098339:0
292,731 shares@ US$71.0060.0% of flowCommon StockSEC:0001562180-24-007702:0
25,771 shares@ US$14.191.0% of flowCommon StockSEC:0001562180-24-005843:0
63,400 shares0Common StockSEC:0001562180-24-001009:0
20,750 shares0Common StockSEC:0001562180-23-000873:0
18,684 shares@ US$65.54093.4% of flowCommon StockSEC:0001562180-23-000495:0
18,100 shares@ US$69.49763.7% of flowCommon StockSEC:0001562180-22-006035:0
50,000 shares@ US$60.008.2% of flowCommon StockSEC:0001562180-22-003045:0
17,787 shares@ US$50.41842.5% of flowCommon StockSEC:0001562180-22-002687:0
43,297 shares0Common StockSEC:0001562180-22-001104:0
50,000 shares@ US$77.1079.9% of flowCommon StockSEC:0001562180-21-005938:0
5,000 sharesCommon StockSEC:0001437749-21-016942:0
33,333 shares@ US$60.005.0% of flowCommon StockSEC:0001562180-21-004197:0
32,833 shares@ US$55.004.5% of flowCommon StockSEC:0001562180-21-003684:0
13,109 shares@ US$52.98161.7% of flowCommon StockSEC:0001562180-21-003441:0
22 of 22 declarations
